Focuses on early detection and personalised prevention of Lynch syndrome, an inherited cancer-predisposition condition.Aims to improve risk assessment tools by integrating:
- Genetic markers
- Family history
- Lifestyle and environmental factors
Supports tailored screening and prevention strategies for individuals at increased risk.
Seeks to reduce the incidence of colorectal, endometrial, and other Lynch syndrome–associated cancers. Brings together leading medical institutions and researchers to advance hereditary cancer prevention.
Promotes precision medicine by providing more accurate, individualised risk predictions.
Emphasises patient education and awareness to help individuals understand and manage their cancer risk. Prioritises accessibility and usability, ensuring risk prediction tools are available to diverse populations. Bridges the gap between research findings and clinical practice.
Empowers both patients and healthcare professionals with actionable insights for informed decision-making.
Contributes to improving long-term health outcomes and quality of life for people at risk of Lynch syndrome–related cancers.
Lynch Syndrome Ireland 